We also found that B cells from SLE patients with anti-TRIM21 Ab also have significantly higher abilities to differentiate into plasmablasts and to product Ab, suggesting that anti-TRIM21 Ab may be related to the TRIM21 dysfunction in human SLE pathogenesis. Here, TRIM21 is linked to systemic lupus erythematosus.